Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)

  1. D.S. ALBERTS1,*,
  2. P.Y. LIU2,
  3. S.P. WILCZYNSKI3,
  4. A. JANG4,
  5. J. MOON2,
  6. J.H. WARD5,
  7. J.T. BECK6,
  8. M. CLOUSER1,
  9. M. MARKMAN7

Article first published online: 5 MAR 2007

DOI: 10.1111/j.1525-1438.2007.00882.x

Issue

International Journal of Gynecological Cancer

International Journal of Gynecological Cancer

Volume 17, Issue 4, pages 784–788, July/August 2007

Additional Information

How to Cite

ALBERTS, D.S., LIU, P.Y., WILCZYNSKI, S.P., JANG, A., MOON, J., WARD, J.H., BECK, J.T., CLOUSER, M. and MARKMAN, M. (2007), Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). International Journal of Gynecological Cancer, 17: 784–788. doi: 10.1111/j.1525-1438.2007.00882.x

Author Information

  1. 1

    Arizona Cancer Center, University of Arizona, Tucson, Arizona

  2. 2

    Southwest Oncology Group Statistical Center, Seattle, Washington

  3. 3

    City of Hope National Medical Center, Duarte, California

  4. 4

    Southern California Permanente Medical Group, Riverside, California

  5. 5

    University of Utah Health Science Center, Salt Lake City, Utah

  6. 6

    University of Arkansas for Medical Science, Little Rock, Arkansas

  7. 7

    MD Anderson Cancer Center, Houston, Texas

*David S. Alberts, MD, Arizona Cancer Center, University of Arizona, Box 245024, 1515 North Campbell Avenue, Tucson, AZ 85724-5024, USA. Email: dalberts@azcc.arizona.edu; Southwest Oncology Group (SO211), Operations Office, 14980 Omicron Drive, San Antonio, TX 78245-3217, USA.

Publication History

  1. Issue published online: 13 JUL 2007
  2. Article first published online: 5 MAR 2007
  3. Accepted for publication December 19, 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (92K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (92K)